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Abstract 10 
Cardiac dysfunction (CD) importantly contributes to mortality in trauma patients, who 11 
survive their initial injuries following successful haemostatic resuscitation. This poor 12 
outcome has been correlated with elevated biomarkers of myocardial injury, but the 13 
pathophysiology triggering this CD remains unknown.  14 
We investigated the pathophysiology of acute CD after trauma using a mouse model of 15 
trauma haemorrhage shock (THS)-induced CD with echocardiographic guidance of fluid 16 
resuscitation, to assess the THS impact on myocardial integrity and function. Mice were 17 
subjected to trauma (soft tissue and bone fracture) and different degrees of haemorrhage 18 
severity (pressure controlled ~MABP <35mmHg or <65mmHg) for one hour, to characterise 19 
the acute impact on cardiac function. In a second study, mice were subjected to trauma and 20 
haemorrhage (MABP<35mmHg) for one hour, then underwent two echocardiographic-21 
guided resuscitations to baseline stroke volume at 60 min and 120 min, and were monitored 22 
up to 180 min  to study the longer impact of THS following resuscitation. Naïve and sham 23 
animals were used as controls. 24 
At 60 min post-THS injury, animals showed a lower cardiac output (CO) and stroke volume 25 
(SV) and an early rise of heart fatty acid-binding protein (H-FABP=167±38 ng/ml; 90% 26 
increase from shams, 3.54±3.06ng/ml), when subjected to severe haemorrhage and injury. 27 
Despite resuscitation, these animals maintained lower CO (6 ml/min vs 23ml/min), lower SV 28 
(10 μl vs 46 μl; both ~75% decreased), and higher H-FABP (levels (340±115 ng/ml vs 29 
10.3±0.2ng/ml; all THS vs. shams, P<0.001) at 180 min post-TH injury. Histopathological 30 
and flow-cytometry analysis of the heart confirmed an influx of circulatory leukocytes, 31 
compared to non-injured hearts. Myocardial injury was supported by an increase of troponin I 32 
and h-FABP and the widespread ultrastructural disorganisation of the morphology of 33 
sarcomeres and mitochondria. DNA fragmentation and chromatin condensation driven by 34 
leakage of apoptosis-inducing factor (AIF) may suggest a mitochondria-driven progressive 35 
cell death.  36 
THS modelling in the mouse results in cardiomyocyte damage and reduced myocardial 37 
function, which mimics the cardiac dysfunction seen in trauma patients. This CD model may, 38 
therefore, provide further understanding to the mechanisms underlying CD and act as a tool 39 
for developing cardioprotective therapeutics to improve survival after injury. 40 
 41 
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Introduction 50 
Trauma is a large and growing problem worldwide, accounting for 10.1% of the global 51 
burden of disease [1], with half of all trauma deaths being due to excessive bleeding and the 52 
subsequent severe shock [2, 3]. New paradigms of haemostatic resuscitation to manage 53 
coagulopathy have led to large decreases in mortality worldwide [4, 5]. With more patients 54 
surviving the initial bleeding episode, cardiac dysfunction is increasingly common and an 55 
important determinant of outcome.  Over half of all critically injured trauma patients admitted 56 
to intensive care develop cardiovascular dysfunction within the first 48 hours, of which 20% 57 
will die [6]. Identifying these patients early in their care and rescuing them from this 58 
downward trajectory would have a dramatic impact on trauma mortality.  59 
Cardiac dysfunction in trauma patients is initially difficult to recognise, as it develops within 60 
the context of hypovolaemia and a widespread inflammatory response [7]. Patients often 61 
initially show a normal cardiac response with a high cardiac output, but over a relatively short 62 
period they experience a dramatic fall in SV and CO, despite inotrope and vasopressor 63 
support.  We have previously shown that trauma patients have elevated levels of biomarkers 64 
of myocardial damage within the first 2 hours of injury, and this is associated with increased 65 
risks of adverse cardiac events and mortality [8, 9]. Cardiac histopathology in non-survivors 66 
has shown multiple pathological identifiers of indirect or secondary cardiac injury [10, 11]. 67 
The pathophysiology and mechanisms of secondary cardiac dysfunction are unknown, with 68 
most critical care studies limited to sepsis [12]. There is some pre-clinical evidence for the 69 
development of cardiac injury and dysfunction arising as an indirect consequence of trauma 70 
and haemorrhage in pigs [13] and in rodents [14-16], suggesting a local cardiac inflammatory 71 
response as the main driver of cardiomyocyte structural and functional damage.  72 
Our overall aim for this study was to investigate the pathophysiology of cardiac dysfunction 73 
after trauma by implementing a clinically relevant murine model of post trauma haemorrhage 74 
cardiac dysfunction. Specifically, our objectives were to: 1) determine the nature and extent 75 
of myocardial damage and cardiac dysfunction in an un-resuscitated model of trauma 76 
haemorrhage; 2) determine the progression of cardiac dysfunction over time in a resuscitated 77 
model of trauma haemorrhage; and 3) explore the inflammatory myocardial response and 78 
ultrastructural integrity, to elucidate possible mechanistic pathways for cardiomyocyte cell 79 
damage.  80 
 81 
Materials and methods 82 
 83 
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Ethical statement 84 
All animal procedures were carried out under a Project Licence (PC5F29685) approved by 85 
the Animal Welfare and Ethical Review Body at Queen Mary University of London and the 86 
UK Home Office, in accordance with the EU Directive 2010/63/EU. All animal facilities and 87 
suppliers have been approved by the UK Home Office Licensing Authority and meet all 88 
current regulations and standards for the UK. A total of 98 mice were used for the work 89 
described in this study (details in supplemental Table 1).  90 
For this study we used n=6-10 animals per group, to provide a valuable discriminatory power 91 
of 90% with a significant level α =0.05 to detect up to 15-20% relative differences in primary 92 
outcomes (lactate levels, cardiac function, cardiac injury biomarkers). Experimental planning 93 
for data randomization and blinded data acquisition and analysis was carried out following 94 
the ARRIVE guidelines [17]. 95 
Animal housing and husbandry  96 
Adult male C57BL/6 mice (weight range 25-30g; 9-11 weeks old) were obtained from 97 
Charles River Laboratories (Margate, UK). Health screens provided by the official vendor 98 
indicated that animals were free of known pathogens in accordance with FELASA guidelines 99 
for health monitoring of rodent colonies [18]. Animals were housed in groups of 4-6 per 100 
individually ventilated cage (IVC; Allentown Europe, UK), in a 12 h light dark cycle (06:30 - 101 
18:30 light; 18:30 - 06:30 dark), with controlled room temperature (21 ± 1°C) and relative 102 
humidity (40-60 %). Animals were allocated to cages on arrival and remained in the same 103 
social group throughout the study, including a 7-day acclimatization phase prior to any study, 104 
with ad libitum access to standard diet and water. 105 
Induction of haemorrhagic traumatic injury 106 
Animals were anaesthetised (Isoflurane: 4-5% induction, 0.5-1.5% for maintenance in 0.8-1lt 107 
/min 100% medical O2). Anaesthesia depth was controlled clinically and by haemodynamic 108 
monitoring (Mean Arterial Blood Pressure; MABP).  Core temperature was maintained at 109 
36± 1oC throughout the study with a homoeothermic blanket (Harvard Apparatus Ltd., UK) 110 
and heat lamps. All experiments were carried out under terminal anaesthesia with no 111 
recovery, and all animals were humanely culled at the end of the experiment.  112 
A 1cm incision was made in the middle of the cervical skin and the left jugular vein was 113 
cannulated [polyethylene tubing pre-flushed with heparinised saline (25 IU/mL); Portex. 114 
Smith’s Medical Int. Ltd. Kent, UK] The right carotid artery was then cannulated in the same 115 
fashion and connected to a pressure transducer (Capto SP 844, AD Instruments, UK) attached 116 
to a PowerLab 8/30 (ML870, AD Instruments Ltd, Oxford, UK) to monitor MABP using the 117 
LabChart software (ADInstruments Ltd, UK). The neck incision was covered and regularly 118 
checked for evidence of line displacement and/or bleeding. If either of these developed, the 119 
animal was euthanised and removed from the study. 120 
A 2cm midline laparotomy was then performed, and the rectus muscle was crushed using 121 
forceps in a systematic fashion in each animal. The abdominal area was examined to exclude 122 
inadvertent iatrogenic injury and/or bleeding, and then the incision was closed using 5.0-123 
prolene suture material (Ethicon, UK). Immediately thereafter, animals were subjected to a 124 
bilateral hind limb fracture. Fractures were performed using a closed, manual 3-point bending 125 
technique. Following 5 minutes’ stabilisation after traumatic injury, a ‘baseline’ MABP was 126 
recorded. Then, a pressure-controlled haemorrhage via the carotid cannula was induced to 127 
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achieve a target MABP of 30 – 40mmHg to reach a Traumatic haemorrhagic shock state 128 
(THS). Animals underwent a 60-minute observation period, during which the target blood 129 
pressure (30-40mmHg) was maintained with removal of blood as required via the carotid 130 
cannula. Shed blood was kept warm in a heparinised 1mL syringe (25 IU/mL), which was 131 
occasionally agitated to prevent thrombus formation. In-dwelling vascular catheters were 132 
intermittently flushed with small volumes of heparinised saline and wound sites checked for 133 
signs of haemorrhage. All volumes of heparinised saline were taken into account when 134 
recording volumes of shed and reinfused blood.  135 
Sham controls underwent cannulation of the carotid artery for invasive MABP monitoring 136 
only, without trauma, haemorrhage or fluid resuscitation. 137 
Echocardiography of the left ventricle (LV) was performed at baseline (prior to any traumatic 138 
haemorrhagic intervention), and at defined time-points after injury to assess the impact of 139 
THS injury at 60 (T60), 120 (T120) and 180 (T180) min post THS, using the Vevo 770 high-140 
resolution system (Visualsonics Inc. Toronto, Canada). M-mode short axis measurements 141 
were used to calculate stroke volume (SV), left ventricular end-diastolic volume (LVEDV) 142 
and cardiac output (CO).  Measurements were carried out in triplicate.  143 
The acute impact of THS in cardiac function was studied in animals subjected to sham, 144 
trauma only, THS to 60-70 mmHg MABP or THS to 30-40 mmHg MABP procedures (n=6 145 
/group) following 1h post-intervention, without any resuscitation. At 60 min post THS (T60), 146 
cardiac function and shock status were assessed and animals were culled via terminal 147 
exsanguination and blood samples processed for further analysis (Fig.1A). 148 
To investigate the CD associated with THS, the THS model with a 30-40 mmHg MABP was 149 
extended up to 3h through 2 resuscitation phases at T60 and T120 (THS and sham, 150 
n=10/group) and terminated at T180 . Echocardiography was carried out at T60, T120 and 151 
T180 to assess cardiac function and also to guide the resuscitation volume requirements to 152 
restore the SV to baseline levels during each resuscitation at T60 and T120 (Fig. 2A).  153 
For the first resuscitation (RESUS 1 at T60), the whole shed blood was transfused as a bolus 154 
over 5 minutes via the jugular catheter, and boluses of warmed Hartmann’s solution 155 
(Vetivex11. Dechra Veterinary Products, Shrewsbury, UK) were then administered to reach 156 
SV baseline. In the second resuscitation phase (RESUS 2 at T120), a bolus of Hartmann’s 157 
alone was administered over 5-10 minutes. At each resuscitation, animals received volume 158 
resuscitation to restore left ventricular stroke volume to baseline. During the second 159 
resuscitation, if the target SV was not reached and yet there was no incremental response to 160 
further fluid boluses (and in the confirmed absence of bleeding from wound sites), this was 161 
deemed to represent the completion of the resuscitation phase. All studies were terminated at 162 
T180, through controlled exsanguination via carotid line and confirmation of death via HR 163 
and MABP.  164 
At the end of the experiment, sham animals were culled via terminal exsanguination and 165 
blood samples and tissue taken. 166 
Assessment of shock status 167 
MAPB and heart rate were measured throughout haemorrhage and resuscitation.  Blood 168 
lactate was measured and used as an index of shock and tissue perfusion. Arterial lactate 169 
concentrations (mmol/L) were assessed using the Accutrend Lactate monitor (Roche, 170 
Mannheim, Germany). Echocardiography measured at T60 and T120 before and after 171 
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resuscitation, and at T180 was carried out to assess cardiac function (left ventricle SV). 172 
Hematocrit (Hct; %) and hemoglobin (Hb; g/dL) were measured with a ProCyte Dx 173 
Hematology Analyzer (IDEXX Europe B.V, Hoofddorp, The Netherlands). 174 
Terminal blood sampling and tissue storage 175 
Terminal exsanguination was performed via the carotid catheter only and processed for serum 176 
separation (Z-Gel microtube, Starstedt. Westphalia, Germany). Serum samples were stored at 177 
-80oC. The hearts were removed immediately after the end of the experiment and processed 178 
accordingly to further test specifics.  179 
Cardiac biomarker assessment  180 
Serum heart fatty acid-binding protein (H-FABP) levels were assayed using commercially 181 
available mouse specific enzyme-linked immunosorbent assay (ELISA Cat. No. HFABP-1) 182 
kit (supplied by Life Diagnostics Inc., West Chester, PA, USA.). ELISAs were performed in 183 
accordance with the manufacturer’s instructions. Standard curves for all ELISAs were plotted 184 
and dilution-corrected sample concentrations were interpolated from the standard curve. 185 
Immunohistochemistry analysis  186 
At 3h THS, a subset of animal (n=3 naïve, n=5 THS) were terminally anaesthetised and 187 
cardiac tissue was immediately fixated (10% NBF). Naïve animals were housed together 188 
under the same conditions but did not have any surgical intervention, trauma, haemorrhage or 189 
fluid resuscitation. Cardiac tissue was paraffin-fixed for histology and immunohistochemistry 190 
(IHC). Sections (7um) were deparaffinised and hydrated through xylene and ethanol baths. 191 
Sections were subjected to antigen retrieval (10mM of citrate buffer, pH 6.0, 10 min in 192 
microwave) and then cooled at room temperature. Tissue was permeabilised with 10% 193 
Triton-X in PBS for 15 min and then blocked with 10% goat or donkey serum, 1% bovine 194 
serum albumin (BSA) in PBS for an hour, at room temperature (RT). The following primary 195 
antibodies diluted in blocking solution were used (overnight incubation in a humid chamber 196 
at 4°C): goat anti-ionized calcium binding adaptor molecule 1 (Iba-1; for macrophages and 197 
monocytes 1:500; Wako Chemicals USA, Inc., Richmond, VA; Cat#ab109497),  rat anti-198 
Lymphocyte antigen 6 complex, locus G (Ly6G-clone 1A8; for neutrophils 1:200; 199 
BioLegend,  London , IK; Cat# 127602); rabbit anti-mouse cleaved caspase-8 1:200 (Asp387; 200 
Cell Signalling Tec.; Cat#8592); rabbit anti-mouse  MTCO2 (1:125; Abcam plc, Cambridge, 201 
UK; Cat#ab110258) or rabbit polyclonal anti-AIF (1:100; Abcam, UK; Cat#ab2086). The 202 
secondary antibodies were donkey anti-goat IgG 568, goat anti-rat 594 IgG, goat anti-rabbit 203 
IgG 488 or goat anti-mouse IgG 594 (Molecular Probes, Leiden, the Netherlands; 1:400 in 204 
PBS). Sudan black (0.3% w/v in 70% ethanol) was used to reduce autofluorescence and 205 
Hoescht 33342 stain (Sigma-Aldrich, Gillingham UK; 1ug/ml of PBS) was used to visualise 206 
nuclei. Slides were mounted and cover-slipped using Vectashield mounting medium (H-1000, 207 
Vector Laboratories, Burlingame, CA).  208 
For calculations, 2 slides per animal with at least 18 fields were captured across the short-axis 209 
LV myocardium stained section. Images were viewed (x400) and photographed using a Zeiss 210 
Axioskop 2 microscope (Carl Zeiss, Jena, Germany) with a Hamamatsu camera (C4742-95; 211 
Hamamatsu Photonics K.K., Hamamatsu, Japan). Analysis was done using the ImageJ 212 
analysis software for counting the number of positively stained cells. Total nuclei count was 213 
measured to normalise percentage of positive stained cells across fields. All imaging 214 
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acquisition and analysis were carried out blinded to the experimental interventions, and data 215 
were only allocated to the specific experimental group at the end of the analysis. 216 
Flow Cytometry full heart analysis  217 
At 3h post-study, a subset of animals (n=6 naïve, n=5 sham-subjected to vessel cannulation 218 
and terminal anaesthesia only, n=5 THS) were intracardially perfused with heparinised saline 219 
under terminal anaesthesia. The hearts were then immediately isolated, cut into 1 mm3 pieces 220 
and dissociated by incubation with papain (Merck, UK) and DNAse I (ThermoFisher 221 
Scientific, UK) for 30 minutes at 37C. Following lysis of residual red blood cells (RBC 222 
Lysis Buffer, Biolegend, UK), cell suspensions were incubated with CD16/CD32-block 223 
(Biolegend, UK) for 30 minutes at 4C, followed by incubation for 30 minutes at 4C with 224 
PE-conjugated anti-CD45 to define immune cell populations, and FITC-conjugated anti-225 
Ly6C/G (clone RB6-8C5) and APC-conjugated anti-F4/80 (all ThermoFisher Scientific, UK) 226 
to differentiate neutrophils (F4/80Neg, Ly6C/GHi) from pro-inflammatory (F4/80Pos, 227 
Ly6C/GInt) and anti-inflammatory (F4/80Pos, Ly6C/GLow) monocytes/macrophages [19, 228 
20]. Cells were then analysed by flow cytometry using a BD FACSCanto II instrument (BD 229 
Biosciences) and FlowJo 8.8.1 software (TreeStar Inc., FL, USA). In all cases, 20,000 singlet 230 
CD45Pos events were analysed per sample; positive staining was defined by inclusion of 231 
fluorescence-minus-one controls for all antigens. 232 
Transmission electron microscopy (TEM)  233 
TEM was used to study micro-structural changes associated to specific cell injury and death 234 
in the cardiomyocyte following THS. In a subset cohort of THS and sham animals from the 235 
3h studies, the animals were humanely killed by overdose of anaesthesia and the heart tissue 236 
immediately dissected, cut into smaller tissue specimen (~1mm3), and fixed in 2% 237 
glutaraldehyde. Fixed tissue was washed three times in cacodylate buffer 0.1 M pH 7.4 and 238 
then incubated in 1% osmium tetroxide in ddH2O for 2 hrs at 4C. After 3 washes in ddH2O, 239 
specimens were dehydrated (progressive incubation from 25% to 100% acetone) following 240 
by impregnation in an increasing concentration of the epoxy resin Araldite 502 (from 25 to 241 
100% of araldite in acetone) used as the embedding medium for TEM. Samples were stored 242 
in fresh araldite for up to 72hrs and then stored at 60°C for 48hrs until the block was hard. 243 
Protein expression in the heart  244 
Western blotting (WB) was used to study biochemical changes associated to cardiomyocyte 245 
injury (troponin I, H-FABP) and cell death pathways (Caspase 8 and Apoptosis Inducing 246 
Factor-AIF) following THS. Tissue from THS (n=6) and sham (n=6) animals was used. At 3h 247 
post-study, animals were deeply anaesthetised and heart tissue was immediately dissected, 248 
weighted and immersed in RIPA buffer [0.1g/1ml  w/v;  50 mM TrisHCl (pH 7.4), 150 mM 249 
NaCl, 1% Triton X-100, 0.5% sodium deoxylcholate, 0.1 % SDS, 1 mM EDTA, 10 mM NaF 250 
in ddH2O] with a cocktail of protease inhibitor and phosphatase inhibitor tablets (Pierce™ 251 
Protease and Phosphatase Inhibitor Mini Tablets Cat no88668, Sigma-Aldrich, UK). The 252 
tissue was minced in RIPA on a cooling slide on dry ice and mash in Dounce homogenizer. 253 
The sample was then sonicated (50 pulses in rounds of 10 s with 10 s rest).  Samples were 254 
spun (@13000 rpm in cooling centrifuge for 20 min) and the supernatant protein sample was 255 
collected. Protein concentrations were determined by Bradford assay. Equal amounts of 256 
protein sample were mixed with NuPAGE® MOPS SDS Running Buffer. 20X)-NP0001 was 257 
made up and a tank filled. Bolt™ 4-12%, 10-well NW04122BOX) Bis-Tris Plus Gel was 258 
inserted into the tank; 10ul of samples were loaded with protein ladder (RPN800E-GE health 259 
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care) into 10 well NuPage Bis-Tris Mini gel. Optical density was determine using ImageJ 260 
software (NIH).  A cardiac tissue specific, mouse monoclonal troponin I antibody (Ab10231, 261 
Abcam, UK; 24kDa) was used for the labelling of troponin. Caspase-8 (rabbit monoclonal 262 
anti-cleaved caspase 8; 8592S; Cell Signalling, UK; 41kDa) expression was used as a marker 263 
of activation of death receptor initiated cell death pathway. AIF (rabbit polyclonal anti-AIF; 264 
Ab2086; Abcam, UK; 67 kDa) expression and location was assessed by WB analysis, with 265 
the tissue homogenates being processed for differential centrifugation to assess the sub-266 
cellular compartmentation, removing the large organelles nuclei, cellular debris and intact 267 
cells, and allowing for selective extraction of the cytosol and mitochondria using Cytosol and 268 
Mitochondrial Extraction Buffer Mix containing DTT and Protease Inhibitors. MTCO2 269 
(Anti-MTCO2; Ab198286; Abcam, UK; 1/150 - 25 kDa) and GAPDH (Anti-GAPDH 270 
antibody; Ab8245; Abcam, UK) were used as a mitochondrial and cytosol markers, 271 
respectively.  272 
Statistical analysis 273 
Lactate levels (mmol/L), MABP measurements (mmHg), resuscitation fluids (ml), 274 
echocardiographic LV data (CO=ml/min; SV=µl; LDEDV=µl), % of inflammatory cells 275 
(neutrophils / monocytes / macrophages) and H-FABP serums levels = ng/ml) were 276 
expressed using mean values, with standard deviation (SD).  Statistical analysis was 277 
performed using GraphPad Prism 8 (GraphPad Software, San Diego, USA). Normally 278 
distributed data was analysed using Student’s two-tailed t test or one-way ANOVA, followed 279 
by Tukey’s multiple comparison test. Non-normally distributed data was analysed with 280 
Kruskall-Wallis and Mann-Whitney U test analysis. P<0.05 was taken to represent 281 
significance. All analysis was performed blinded to the experimental interventions. (Further 282 
details in supplementary Table 2). 283 
Results: 284 
Myocardial injury after trauma and haemorrhage  285 
The trauma haemorrhage model demonstrated progressive myocardial damage and cardiac 286 
dysfunction following an hour of trauma and haemorrhage without resuscitation (Figure 1).   287 
We examined cardiac effects of trauma alone, trauma and haemorrhage to target MABP of 288 
60-70mmHg (THS 60-70); and to a target an MABP of 30-40mmHg (THS 30-40), achieving 289 
different depths of shock severity (Figure 1A, supplemental Table 3)  Myocardial damage, as 290 
measured by serum H-FABP concentrations, increased with increasing model severity, and 291 
were significantly elevated for the most severe THS group (THS 30-40 = 166.69 ± 292 
38.64ng/ml), compared to sham, trauma only and 60-70 mmHg THS group (p<0.01). (Fig 293 
1C). At end-experiment, stroke volume and cardiac output were significantly decreased from 294 
baseline in all groups (Fig 1D-1F).  In the THS 30-40 group, with over 30% blood loss, 295 
cardiac output was 87% lower than baseline (Fig 1E ) at 1-hour post trauma compared to 296 
sham and trauma-only groups (p<0.001, Figure 1E).  297 
Cardiac dysfunction following myocardial damage 298 
In order to determine the functional effects of myocardial damage, we extended our TH 30-299 
40mmHg model for 3 hours to include two resuscitation phases at 60 and 120 minutes post-300 
haemorrhage (Figures 2A and 2B).  Shock severity worsened over time despite the two 301 
resuscitation steps (Figures 2B & C), with serum lactate reaching a median of 7.9 ±5.2 302 
mmol/L at 180 minutes (from 1.4±0.37mmol/l at baseline p=0.004, supplemental Table 4).  303 
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MABP increased immediately after resuscitation, but then progressively declined, despite 304 
transient increases with volume resuscitation.  End-experiment MAP was 44% lower than 305 
post Resus-1 levels (43.3±8 vs 77.4±5mmHg Figure 2B; supplemental Table 4).  Hb 306 
concentration and Hct were not significantly different between the THS group and sham, at 307 
3h (Hb 14.5±1.6 vs 13.2±1.4 and Hct 47.5±8.7 vs 43.1±5.4, in sham and THS groups, 308 
respectively; supplemental Table 2 and Fig 1). 309 
On functional echocardiographic assessment, volume resuscitation to normalise stroke 310 
volume did not maintain LVEDV, stroke volume or cardiac output. Mean LVEDV was only 311 
23% of baseline at end-experiment (16.40µl vs 76.17µl; p<0.0001); stroke volume was 22% 312 
of baseline (10.5µl vs 47.1µl, p<0.0001) and total cardiac output was 30% from baseline 313 
(5.8µl vs 22.4µl, p<0.0001, Figures 2E-G, Table S2). In line with these findings, H-FABP 314 
concentrations continued to increase from T60 min post-THS, rising to a mean of 340ng/ml 315 
at end-experiment compared to 116.7ng/ml at T60 (p=0.003) and 10.3 ng/ml compared to 316 
sham animals at end-experiment, p<0.001) (Table 2).  Despite resuscitation, 50% of animals 317 
had died by 3h post-haemorrhage. (Figure 2H). 318 
Myocardial inflammation and structural damaged following THS impacts on 319 
cardiomyocyte survival  320 
From our in situ IHC-analysis in the myocardium, a significantly higher % of neutrophils 321 
(Ly6G stained cells) was identified in the heart of the THS group compared to naïve animals 322 
(0.15±0.07 vs. 0.8±0.1 % of positive LyG6 cells, respectively; P=0.02) (Fig.3A); a high 323 
presence of macrophages and monocytes were also identified in the THS group (1.7±0.01 vs. 324 
0.3±0.01 % positive Iba-1 cells in THS vs naïve, respectively; P=0.001). (Fig. 3B).  325 
From the flow cytometry analysis carried out following ex vivo heart cells disaggregation, a 326 
significantly higher number of neutrophils were identified in THS group compared to naïve 327 
non-injured animals (11.7±5.2 vs. 3.4±2.7 % F4/80Neg, Ly6C/GHi cells; one way ANOVA 328 
with Tukey’s multiple Comparison P=0.01) (Fig3.D). Sham animals did not differ from naïve 329 
or THS (6.4±3. 9% F4/80Neg, Ly6C/GHi cells). When investigating monocyte cell 330 
population, we identified a statistically higher ratio of pro-inflammatory (F4/80Pos, 331 
Ly6C/GInt) vs anti-inflammatory (F4/80Pos, Ly6C/GLow) monocytes in the THS group 332 
compared to the naïve and sham animals (1.14±0.8 for THS group vs 0.25±0.1 for naïve 333 
group and 0.32±0.1 for sham group; P=0.006 and P=0.01, respectively) (Fig.3H). There was 334 
also a trend to shift the presence of pro vs. anti-inflammatory monocytes in the hearts of THS 335 
animals, compared to that for the naïve and sham groups; but these data did not reach the 336 
threshold for statistical significance (Fig. 3F,G).  337 
TEM analysis demonstrated significant morphological changes within the myocardium, with 338 
interstitial oedema and widespread disorganisation of the cardiac myofibrillar ultrastructure, 339 
and a relaxation of the sarcomere in the cardiomyocytes (Fig. 4A). We identified the presence 340 
of poorly circumscribed mitochondria distributed in a disorderly fashion across cardiac 341 
muscle fibres, with significant structural changes. In THS animals, 33% of the mitochondria 342 
contained amorphous dense bodies, in comparison to 23% in the sham animals (p=0.006). 343 
Mitochondrial swelling, with loss of electron dense material from the matrix and breakdown 344 
of the cristae and vacuolation, was also observed in THS animals (Fig. 4B).  The nuclei of 345 
this THS group also exhibited signs of irreversible structural changes, such as margination of 346 
chromatin, associated with surrounding oedema, chromatin condensation and rarefaction of 347 
the nucleoplasm, where there is loss of the chromatin (Fig.4C-E), compare to sham animals 348 
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(Fig4.F-H). Most of these lesions are consistent with presence of myocardial ischaemia injury 349 
the THS hearts (Fig 4). 350 
Myocardial damaged was confirmed by the reduced levels of H-FABP in the myocardium of 351 
the THS hearts (p=0.06 NS; p=0.04*, respectively; two-tailed unpaired t-test; means ± SD), 352 
indicating the loss /release of these proteins, attributable to myocardial injury. (Fig.4I,J).  353 
A significant decrease in caspase 8 expression in THS was seen on IHC (Fig 4 K) is 354 
suggestive that the cardiomyocte damage seen is not dependent upon death receptor initiated 355 
or protease dependent apoptosis. The difference in caspase 8 on WB although downward 356 
trending was not statistically significant (Fig 4L). The total AIF expression was similar 357 
between Sham and THS models (0.20 vs 0.17 respectively, NS; Fig 5A), but a 358 
compartmentalisation of AIF outside the mitochondria was observed in the TH models. The 359 
decrease in the mitochondrial AIF in comparison to cytosolic AIF in the THS hearts 360 
(mitochondria vs. total cell P=0.04 and mitochondria vs. supernatant/cytosol P=0.04; Fig 5B) 361 
suggests a leakage of the mitochondrial AIF into the cytosol, with the potential activation of a 362 
mitochondrial driven cell death pathway (Fig.5A-D).  363 
Discussion 364 
Our study confirms that the preclinical modelling approach that we have developed 365 
physiologically and biochemically mirrors the cardiac dysfunction seen in bleeding trauma 366 
patients. Traumatic injury and controlled haemorrhage induced significant acute cardiac 367 
damage despite subsequent echocardiography-guided volume resuscitation. These changes 368 
were associated with demonstrable myocardial cell death and inflammation leading to 369 
reduced survival.  370 
In our unresuscitated model, we identified cardiac functional changes and myocardial damage 371 
with comparable elevations in the cardiomyocyte damage molecule H-FABP [21] to those 372 
reported in clinical studies [8, 22]. The associated functional decreases in cardiac output were 373 
at least in part related to the loss of stroke volume.  However, our resuscitated model, with 374 
confirmed restoration of volume preload, demonstrated a persistent and progressive loss of 375 
cardiac function associated with increasing myocardial injury indicated by further elevations 376 
in H-FABP. Catecholamine release with increased inotropy will undoubtedly compensate for 377 
some degree of cardiomyocyte loss.  However in our model, volume resuscitation to baseline 378 
LVEDV was not able to restore cardiac function to pre-shock levels. This resultant cardiac 379 
dysfunction is increasingly recognised as a key determinant of critical care utilization and 380 
survival in trauma patients [10, 23, 24].  381 
Cardiac dysfunction is well known in sepsis [12, 25], but the aetiology of trauma induced 382 
myocardial injury likely has different underlying pathophysiology [1-16, 26]. We observed 383 
an acute cardiac inflammatory response, with an increase in monocytes/macrophages and 384 
neutrophils infiltration in the heart is identified following THS injury.  This may be driven by 385 
the systemic inflammatory response to trauma [15, 26], or may be a direct response of the 386 
immune system to cardiomyocyte cell death. The acute recruitment of monocytes and 387 
neutrophils from circulation into the myocardium has also been reported in cardiac stress 388 
ischemic conditions [27]. The persistence of this myocardial inflammation response may lead 389 
to further endogenous cytokine production and leukocyte recruitment and infiltration, 390 
increasing oxidative stress, cell damage and cardiac dysfunction [28]. 391 
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We observed severe cardiomyocyte ultrastructural and organelle dysfunctional damage by 3h 392 
post trauma, with myofibrillary disarray, relaxation of sarcomeric proteins, mitochondrial 393 
vacuole formation, membrane disruption and chromatin features consistent with irreversible 394 
damage. Such cellular stress features, augurs of cell death, have been described in rodent 395 
cardiomyocytes following ischemia-reperfusion [29]. Furthermore, the increased 396 
translocation of mitochondrial AIF into the cytosol, and then into the nucleus, confirms the 397 
activation of cell death pathways associated with cell death. This presence of AIF leakage in 398 
addition to the reduced expression of caspase 8, may indicate the involvement of the alternate 399 
cell death pathway of necroptosis as a principle mode of cardiomyocyte cell death in trauma 400 
[30, 31]. Many alarmins released following trauma (ATP, DNA, histones, HMGB-1, HSP70) 401 
have been associated with necroptosis signalling [32], and such necroptosis has already been 402 
identified as central to other sterile inflammation conditions such as acute pancreatitis [33] 403 
and organ injury[34]. Our data raises the possibility of mitochondrial mediated necroptosis 404 
triggered by specific extracellular alarmins as the underlying cardiomyocyte cell death 405 
pathways, leading to cardiac dysfunction in trauma patients. However, the role of AIF and 406 
necroptosis is still poorly understood in the realm of organ injury and unexamined in the 407 
context of trauma. Therefore, it is pertinent to conduct further studies to modulate AIF 408 
translocation and examine its effect on necroptosis, cell survival and therefore cardiac 409 
dysfunction in models prior to translation to humans. Our modelling approach will support 410 
further mechanistic studies on the role of inflammatory mediators in driving specific 411 
tissue/organ dysfunction after trauma, particularly allowing for the use of transgenic animals 412 
for inflammatory pathways.  413 
There are several limitations to this study.  We limited our model to 3 hours, and longer 414 
durations will be required to examine the longer term impacts of injury on cardiac function. 415 
The implementation of serial echocardiography to guide resuscitation is unique in trauma 416 
models and delivers a new in-vivo understanding of cardiac dysfunction in trauma 417 
haemorrhage.  However, it was difficult to assess myocardial contractility with ultrasound 418 
and further advanced imaging approaches such as speckle tracking or MRI tagging could be 419 
used to explore this, as well as ex-vivo isolated heart techniques. Monitoring of other 420 
clinically relevant resuscitation parameters like urine output, arterial blood gas or central 421 
venous pressure could also have been explored, but their implementation in this echo-guided 422 
trauma mouse model remain challenging due to low blood volumes and technical limitations. 423 
Our inflammatory and biochemical analyses identified cardiomyocyte cell death suggesting, 424 
but not definitive of, activation of necroptosis pathways.  Further work will be required, to 425 
fully characterise the cell death mechanism and its relationship with the sterile inflammatory 426 
response.  427 
Cardiac dysfunction is now a major mode of trauma haemorrhage death after admission. We 428 
have identified the development of severe and irreversible myocardial damage, despite fluid 429 
resuscitation, leading to cardiac dysfunction and death. We pose AIF-driven necroptosis as a 430 
possible underlying mechanistic pathway for the cell death. Myocardial protection through 431 
novel management strategies and therapeutic approaches represents a major opportunity for 432 
improving survival after major trauma.  433 
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 574 
Figure legends: 575 
Figure 1: Characterisation of the shock status and cardiac dysfunction at 60 min post 576 
traumatic haemorragic shock injury (1h post-THS). A) Modelling strategy describing the 577 
experimental set up with vessel cannulations, traumatic soft and hard tissue injury and 578 
pressure-controlled haemorrhage. B)Median values, interquartile range and range of arterial 579 
blood lactate levels at 60min post-THS between the experimental groups (S= sham with only 580 
vessel cannulation only; T=Traumatic injury alone; TH 60-70=THS with 60-70 mmHg 581 
MABP and TH 30-40=THS with 30-40 mmHg MABP). **P<0.001 between TH 30-40 and S, 582 
T and TH 60-70. C) Serum H-FABP levels as a myocardial injury biomarker at 60min post-583 
THS between the S, T and THS 60-70 and 30-40mmHg groups, showing a significant 584 
difference in the THS-30-40 group vs. the others (**P<0.001). D) Representative 585 
echocardiographic images across the longitudinal heart axis showing the collapsed LV in 586 
THS animals at 60 min post-injury, in comparison with baseline non-no injured heart; yellow 587 
line depicts the endocardium; red line depicts epicardium. E) Cardiac outcome (CO; ml/min) 588 
at 60 min post-injury, showing the impact of pre-load effects on the THS 60-70 and the THS 589 
30-40 groups compared to S and T groups (*P<0.05, **P<0.001 between groups; **P<0.01 590 
TH 60-70 versus TH 30-40). D) Stroke volume ( SV; uL) at 60min post-injury, showing the 591 
impact of pre-load effects on the THS 60-70 and the THS 30-40 groups (*P<0.05, **P<0.001 592 
between groups). 593 
Figure 2: Characterisation of the 3h THS cardiac dysfunction (CD) model . A) 594 
Modelling strategy: mice subjected to trauma haemorrhage are held at a MAP of 30-40mmHg 595 
for an hour and then resuscitated with shed blood & crystalloid (Resus1) to their original 596 
stroke volume (SV). Mice are then left for a further hour and resuscitated again (Resus 2) and 597 
then left to complete a 3-hour experiment. Animals undergo two echocardiographic-guided 598 
resuscitations at 60 minutes and 120 minutes to baseline SV.  B) Progressive decrease of 599 
MABP despite pre-load resuscitation fluids. C)  Serum lactate levels increase steadily after 600 
the 1st resus (3.93 ±0.93mmol/L) to T180 post-THS (7.9 ±5.19mmoL). D) Left ventricular 601 
end-diastolic volume (LVEDV) does not regain baseline levels despite resuscitation pre-loads 602 
(Baseline: 76.17 ±10.15 vs. 180 min 16.40 ±12.98 at T180 post-THS; P<0.0001 one-way 603 
ANOVA). E) Cardiac Output (CO; ml/min) and D) SV (uL) indicate the progressive loss of 604 
15 
 
LV function despite pre-load resuscitation. This is observed already following the 1st resus 605 
after T60 THS insult, despite temporary increases in CO and SV immediately following 606 
resuscitations (at T60 and T120; see Table 4). G) Following the initial dosing of shed blood 607 
(SB) during the 1st resus at T60min, the crystalloid fluid require to reach baseline SV is 608 
steadily increased during the 1st and 2nd resuscitation (THS60 min and THs120min, 609 
respectively). E) Impact of CD in the median survival, with 50% decrease survival at 610 
THS180min. 611 
Figure 3: Characterisation of acute cardiac inflammation response in the Trauma 612 
Haemorrhage induced CD murine model (THS).  Immunohistochemistry (IHC) 613 
myocardial analysis shows A) a significant increase in neutrophils (% LyG6 cells) and B)  614 
Monocytes/ Macrophages (% Iba-1 cells) in the THS model (T180 min) compared to naïve 615 
(p< 0.001**,p=0.02*; two-tailed unpaired t-test).  Data is presented as means ± SD. C) 616 
Representative IHC microphotographs in heart section in a THA and naïve animal (x400) and 617 
zoom insets of the LY6G and Iba-1 staining (red) for the neutrophils and 618 
monocyte/macrophage, respectively, with the nuclei Hoechst staining (blue) in a THS model. 619 
D-H) Flow cytometry assessment of heart-infiltrating leukocytes. D) Representative forward 620 
scatter/side scatter profile and a live cell gate. Following a CD45/side scatter plot to obtain 621 
the CD45+ leukocyte2, Ly6G Hi or low expression with F4/80 plots was used to derived 622 
percentages of pro-inflammatory monocytes (Ly6GHi, F4/80+: M1 phenotype ) and anti-623 
inflammatory monocytes/macrophages ( Ly6GLow, F4/80+: M2 phenotype). The heart from 624 
THS animals showed a significant increase in the M1:M2 phenotype ratio, compared to the 625 
naïve animals. E) A significant presence of neutrophils (% Ly6G+ F4/80- cells) and a high 626 
ratio of inflammatory monocytes (F, G, H; Higher ratio of Ly6GHi, F4/80+ inflammatory 627 
monocytes vs. F4/80+: M2 anti-inflammatory macrophages/monocytes; p<0.001**, p=0.02*; 628 
one-way ANOVA with post-hoc analysis). Data all presented as means ± SD. 629 
Figure 4: Myocardial injury in the trauma haemorrhage induced CD murine model. 630 
TEM shows severe myocardial injury in the heart of THS mice, with interstitial oedema, 631 
widespread disorganisation of the myocardium with relaxation of the sarcomere and poorly 632 
circumscribed mitochondria distributed in a disorderly fashion (A). Significant amounts of 633 
mitochondrial oedema (B) Nuclei shows margination of chromatin, rarefaction of the 634 
nucleoplasm (C) and glycogen depletion (D); and some cardiomyocytes dead cells with 635 
margination of chromatin (E). TEM of sham mice heart tissue shows a well-organised 636 
myofibrils, with mitochondria evenly organised along the cristae sarcomere (F) with intact 637 
nucleus (G) and mitochondria (H). WB analysis of Troponin-I  (cTnI) (I) and H-FABP (J) 638 
expression  shows elevated levels in the  myocardium of THS mice  (p=0.06 NS; p=0.04*, 639 
respectively; two-tailed unpaired t-test; means ± SD ). K, L) Low caspase 8 expression is 640 
observed in heart of THS mice (; IHC p<0.0001; WB p>0.05 compared to sham animals). 641 
Figure 5: AIF localisation in the trauma haemorrhage induced CD murine model. A) 642 
AIF expression as demonstrated by western blot analysis. The total AIF expression is similar 643 
in the Sham and THS models ( 0.20 vs 0.17, respectively).  B) Cellular compartmentalisation 644 
of AIF as demonstrated by WB analysis. Higher proportion of AIF is found outside the 645 
mitochondria in the THS models The mean ratio of mitochondrial AIF (mAIF) to supernatant 646 
AIF (sAIF) is 1.5 in sham compared to 0.4 in THS group, p=0.16. When comparing total AIF 647 
which includes the nucleus, a lower proportion is still found in the mitochondria. Ratio of 648 
mitochondrial AIF (mAIF) to total AIF (tAIF) in sham group is 0.6 compared to 0.3 in THS 649 
animals, p=0.04. This is suggestive of its translocation of the AIF out of the mitochondrion, 650 
potentially to the nucleus, triggering initiation of cells death. IHC sections from TH animals, 651 
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DAPI (blue), AIF (green), MTCO2 (red) and combined images. In the combined images, 652 
localisation of AIF in the nucleus can be seen in the THS (D) which in absent in the sham 653 
animals (C). 654 
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